Anne Creisson

Nice, FR 
Nice, FR 

Overview

Anne Creisson practices practicing medicine in Nice, France.

Her clinical expertise encompasses HER-2 Positive Breast Cancer, Breast Cancer in Men, Breast Cancer, and Bronchiolitis Obliterans.

She is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Nice, 55121, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Impact of a Telephonic Monitoring During Neo Adjuvant or Adjuvant Chemotherapy
Impact of a Telephonic Monitoring During Neo Adjuvant or Adjuvant Chemotherapy
Enrollment Status: Completed
Publish Date: April 23, 2026
Intervention Type: Other
Study Phase: Not Applicable
A Multicenter, Randomised, Open-label Phase II Study to Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
A Multicenter, Randomised, Open-label Phase II Study to Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
Enrollment Status: Unknown
Publish Date: February 12, 2024
Intervention Type: Drug
Study Drugs: Nivolumab, Ipilimumab, Capecitabine
Study Phase: Phase 2
View 1 Less Clinical Trial

9 Total Publications

Impact of renal and hepatic function on dihydropyrimidine dehydrogenase phenotype assessed by enzyme activity in peripheral blood mononuclear cells and uracilemia.
Impact of renal and hepatic function on dihydropyrimidine dehydrogenase phenotype assessed by enzyme activity in peripheral blood mononuclear cells and uracilemia.
Journal: Clinical chemistry and laboratory medicine
Published: July 25, 2025

Frequently Asked Questions about Anne Creisson

Is Anne Creisson a top-rated expert for HER-2 Positive Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Anne Creisson is classified as an Experienced expert for HER-2 Positive Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Anne Creisson participate in research or clinical trials?

Yes. Anne Creisson has published 9 articles and abstracts on conditions like HER-2 Positive Breast Cancer. You can view a list of Anne Creisson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Creisson's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile